These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 20066935)

  • 1. [Evaluation of lithium treatment response in Sardinian bipolar patients].
    Chillotti C; Deiana V; Manchia M; Lampus SF; Ardau R; Severino G; Del Zompo M
    Riv Psichiatr; 2009; 44(1):28-35. PubMed ID: 20066935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lithium response across generations.
    Grof P; Duffy A; Alda M; Hajek T
    Acta Psychiatr Scand; 2009 Nov; 120(5):378-85. PubMed ID: 19807719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Sexual dysfunctions and bipolar disorder: a study of patients submitted to a long- term lithium treatment].
    Zuncheddu C; Carpiniello B
    Clin Ter; 2006; 157(5):419-24. PubMed ID: 17147049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mood stabilizer augmentation in apparently "unipolar" MDD: predictors of response in the naturalistic French national EPIDEP study.
    Hantouche EG; Akiskal HS; Lancrenon S; Chatenêt-Duchêne L
    J Affect Disord; 2005 Feb; 84(2-3):243-9. PubMed ID: 15708422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term stability of cognitive impairment in bipolar disorder: a 2-year follow-up study of lithium-treated euthymic bipolar patients.
    Mur M; Portella MJ; Martínez-Arán A; Pifarré J; Vieta E
    J Clin Psychiatry; 2008 May; 69(5):712-9. PubMed ID: 18435565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rates of remission/euthymia with quetiapine in combination with lithium/divalproex for the treatment of acute mania.
    Sussman N; Mullen J; Paulsson B; Vågerö M
    J Affect Disord; 2007; 100 Suppl 1():S55-63. PubMed ID: 17383736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term clinical effectiveness of lithium maintenance treatment in types I and II bipolar disorders.
    Tondo L; Baldessarini RJ; Floris G
    Br J Psychiatry Suppl; 2001 Jun; 41():s184-90. PubMed ID: 11450181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship of open acute mania treatment to blinded maintenance outcome in bipolar I disorder.
    McElroy SL; Bowden CL; Collins MA; Wozniak PJ; Keck PE; Calabrese JR
    J Affect Disord; 2008 Apr; 107(1-3):127-33. PubMed ID: 17888516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Predictors of prophylactic response to lithium].
    Rohayem J; Baylé JF; Richa S
    Encephale; 2008 Sep; 34(4):394-9. PubMed ID: 18922242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness and medical costs of divalproex versus lithium in the treatment of bipolar disorder: results of a naturalistic clinical trial.
    Revicki DA; Hirschfeld RM; Ahearn EP; Weisler RH; Palmer C; Keck PE
    J Affect Disord; 2005 Jun; 86(2-3):183-93. PubMed ID: 15935238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rational polypharmacy in the bipolar affective disorders.
    Post RM; Ketter TA; Pazzaglia PJ; Denicoff K; George MS; Callahan A; Leverich G; Frye M
    Epilepsy Res Suppl; 1996; 11():153-80. PubMed ID: 9294735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of short-term venlafaxine versus lithium monotherapy for bipolar II major depressive episode: a randomized open-label study.
    Amsterdam JD; Shults J
    J Clin Psychopharmacol; 2008 Apr; 28(2):171-81. PubMed ID: 18344727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjunctive quetiapine in bipolar patients partially responsive to lithium or valproate.
    Sokolski KN; Denson TF
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 Aug; 27(5):863-6. PubMed ID: 12921920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lithium treatment -- moderate dose use study (LiTMUS) for bipolar disorder: rationale and design.
    Nierenberg AA; Sylvia LG; Leon AC; Reilly-Harrington NA; Ketter TA; Calabrese JR; Thase ME; Bowden CL; Friedman ES; Ostacher MJ; Novak L; Iosifescu DV;
    Clin Trials; 2009 Dec; 6(6):637-48. PubMed ID: 19933719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term outcome of patients with bipolar disorder commenced on lithium prophylaxis during hospitalization: a complete 15-year register-based follow-up.
    Licht RW; Vestergaard P; Brodersen A
    Bipolar Disord; 2008 Feb; 10(1):79-86. PubMed ID: 18199244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatments for late-life bipolar disorder.
    Aziz R; Lorberg B; Tampi RR
    Am J Geriatr Pharmacother; 2006 Dec; 4(4):347-64. PubMed ID: 17296540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maintenance treatment in bipolar disorder: a reassessment of lithium as the first choice.
    Coryell W
    Bipolar Disord; 2009 Jun; 11 Suppl 2():77-83. PubMed ID: 19538687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychosensory symptoms in bipolar disorder.
    Ali SO; Denicoff KD; Ketter TA; Smith-Jackson EE; Post RM
    Neuropsychiatry Neuropsychol Behav Neurol; 1997 Oct; 10(4):223-31. PubMed ID: 9359118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alternative approaches to refractory depression in bipolar illness.
    Post RM; Leverich GS; Denicoff KD; Frye MA; Kimbrell TA; Dunn R
    Depress Anxiety; 1997; 5(4):175-89. PubMed ID: 9338110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interacting genes in lithium prophylaxis: preliminary results of an exploratory analysis on the role of DGKH and NR1D1 gene polymorphisms in 199 Sardinian bipolar patients.
    Manchia M; Squassina A; Congiu D; Chillotti C; Ardau R; Severino G; Del Zompo M
    Neurosci Lett; 2009 Dec; 467(2):67-71. PubMed ID: 19818381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.